Phosphonic Acid

Phosphonic Acid

SCHEMBL1162610

O=[PH](O)O.O[SiH](CCc1ccccc1)[SiH2][SiH3]

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.37
NOS1 P29475 2/20 0.37
TDP1 Q9NUW8 3/20 0.36
HDAC2 Q92769 3/20 0.35
HDAC8 Q9BY41 3/20 0.35
HDAC6 Q9UBN7 3/20 0.35
ALDH1A1 P00352 2/20 0.35
HDAC3 O15379 2/20 0.35
HDAC4 P56524 2/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC7 Q8WUI4 2/20 0.35
HDAC10 Q969S8 2/20 0.35
HDAC11 Q96DB2 2/20 0.35
HDAC9 Q9UKV0 2/20 0.35
HDAC5 Q9UQL6 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPK1 P28482 1/20 0.35
ADRA1A P35348 1/20 0.35
SLC6A3 Q01959 1/20 0.35
FFAR1 O14842 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22630854 0.91 TDP1 (0.43) KEAP1NOS1TDP1HDAC2HDAC8
Phosphonic Acid SCHEMBL3817713 0.74 FFAR1 (0.56) KEAP1TDP1HDAC2HDAC8HDAC6
SCHEMBL3482052 0.71 TSHR (0.39) KEAP1NOS1TDP1ALDH1A1CA1
SCHEMBL8381407 0.71 TDP1 (0.46) KEAP1TDP1ALDH1A1SMN1; SMN2ADRA1A
SCHEMBL4327818 0.69 TDP1 (0.48) KEAP1NOS1TDP1HDAC2HDAC8
SCHEMBL4514776 0.68 TDP1 (0.52) KEAP1NOS1TDP1HDAC2HDAC8
Phenethylamine SCHEMBL15397870 0.67 HTR2A (0.73) NOS1ALDH1A1SMN1; SMN2CYP2A6HTR2A
Phosphonic Acid SCHEMBL27776144 0.67 ALDH1A1 (0.48) KEAP1TDP1HDAC2HDAC8HDAC6
Phosphonic Acid SCHEMBL1162721 0.66 CES2 (0.42) KEAP1TDP1HDAC2HDAC8HDAC6
Phenyl Propionic Acid SCHEMBL7827884 0.66 KEAP1 (0.83) KEAP1TDP1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109154604-B Charged surface reversed phase chromatography material method for analysis of glycans modified with amphiphilic strong basic moieties 沃特世科技公司 2023-07-21 CN claimed
EP-2714225-B1 METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS WATERS TECHNOLOGIES CORP (US) 2020-11-11 EP claimed
US-20200332028-A1 CHARGED SURFACE REVERSED PHASE CHROMATOGRAPHIC MATERIALS METHOD FOR ANALYSIS OF GLYCANS MODIFIED WITH AMPHIPATHIC, STRONGLY BASIC MOIETIES WATERS TECHNOLOGIES CORPORATION 2020-10-22 US claimed
EP-3687652-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES Waters Technologies Corporation (US) 2020-08-05 EP claimed
US-20190126241-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES WATERS TECHNOLOGIES CORPORATION 2019-05-02 US claimed
US-20140338429-A1 METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2014-11-20 US claimed
US-20130319086-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2013-12-05 US claimed
WO-2012166916-A1 METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS WATERS TECHNOLOGIES CORPORATION (US) 2012-12-06 WO claimed
US-20120273404-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2012-11-01 US claimed
EP-2462188-A1 HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER Waters Technologies Corporation (US) 2012-06-13 EP claimed
WO-2011017418-A1 HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2011-02-10 WO claimed
CN-117054585-A Charged surface reversed phase chromatography material method for analysis of glycans modified with amphiphilic strong basic moieties 沃特世科技公司 2023-11-14 CN disclosed
US-20230256413-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES WATERS TECHNOLOGIES CORPORATION (US) 2023-08-17 US disclosed
CN-109154604-B Charged surface reversed phase chromatography material method for analysis of glycans modified with amphiphilic strong basic moieties 沃特世科技公司 2023-07-21 CN disclosed
US-11597789-B2 Materials for hydrophilic interaction chromatography and processes for preparation and use thereof for analysis of glycoproteins and glycopeptides WATERS TECHNOLOGIES CORPORATION (US) 2023-03-07 US disclosed
WO-2013158277-A1 METHODS FOR QUANTIFYING POLYPEPTIDES USING MASS SPECTROMETRY WATERS TECHNOLOGIES CORPORATION (US) 2013-10-24 WO disclosed
WO-2012166916-A1 METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS WATERS TECHNOLOGIES CORPORATION (US) 2012-12-06 WO disclosed
US-20120273404-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2012-11-01 US disclosed
EP-2462188-A1 HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER Waters Technologies Corporation (US) 2012-06-13 EP disclosed
WO-2011017418-A1 HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2011-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120273404-A1 HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER SPECC1L, SAMM50, RAB5IF KEAP1 934/4885NOS1 3740/4885TDP1 4772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.